Keeping the biotechnology of antisense in context

[1]  Lyuba Benimetskaya,et al.  Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotide , 1997, Nucleic Acids Res..

[2]  B. Monia,et al.  Anti-tumor activity of C-raf antisense—correction , 1999, Nature Medicine.

[3]  N. Dean,et al.  Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. , 1994, The Journal of biological chemistry.

[4]  D. Spiller,et al.  Optimization of antisense oligodeoxynucleotide structure for targeting bcr-abl mRNA. , 1995, Blood.

[5]  C. Stein,et al.  Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides. , 1998, Nucleic acids research.

[6]  N. Goldstein,et al.  Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Stein,et al.  Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular Matrix (*) , 1995, The Journal of Biological Chemistry.

[8]  D. Spiller,et al.  Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells. , 1995, Nucleic acids research.

[9]  D. Ecker,et al.  Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. , 1992, The Journal of biological chemistry.

[10]  A. Krieg,et al.  Applied antisense oligonucleotide technology , 1998 .

[11]  Yedy Israel,et al.  Tetranucleotide GGGA Motif in Primary RNA Transcripts , 1998, The Journal of Biological Chemistry.

[12]  T. Smetsers,et al.  Bias in nucleotide composition of antisense oligonucleotides. , 1996, Antisense & nucleic acid drug development.